Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells

Abstract

This study examined the effects of ursolic acid (UA) on the proliferation and apoptosis of a human ovarian cancer cell line, CAOV3. The CAOV3 cells were cultured in the RPMI 1640 media and treated with different concentrations of UA (0, 10, 20, 40 μmol/L). The proliferation rate of the CAOV3 cells was determined by MTT assay. The apoptosis rate was measured by flow cytometry. ERK activity was detected by immunoprecipitation and the expressions of p-ERK1/2, MKP-1, Bax and Bcl-2 by Western blotting. The results showed that the proliferation rate was significantly decreased in the cells treated with UA as compared with that in the non-treated cells (P<0.05). The intracellular ERK activity and p-ERK1/2 expression were also reduced in the UA-treated cells, while the MKP-1 expression was elevated. Moreover, the apoptosis was found in the CAOV3 cells exposed to UA; the Bax expression was increased and the Bcl-2 expression decreased. The apoptosis rate in the UA-treated cells was much higher than that in the non-treated cells (P<0.05). It is concluded that UA can inhibit the proliferation of CAOV3 cells by suppressing the ERK activity and the expression of p-ERK1/2. And it can also induce the apoptosis of the CAOV3 cells by up-regulating the Bax expression and down-regulating the Bcl-2 expression.

Keywords

ursolic acid / ovarian cancer / proliferation / apoptosis

References

[1] LiuJ.. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol, 2005, 100(1–2): 92-94

[2] LiuJ.. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol, 1995, 49(2): 57-68

[3] HsuY.L., KuoP.L., LinC.C.. Proliferative inhibition, cell cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci, 2004, 75(19): 2303-2316

[4] HollosvF., LdeiM., CsorbaG., et al.. Activation of cas pase-3 protease during the process of ursolic acid and its derivativeinduced apoptosis. Anticancer Res, 2001, 21(5): 3485-3491

[5] ZhangY.Y., DengT., HuZ.F., et al.. Mechanisms of inhibiting proliferation and inducing apoptosis of human gastric cancer cell line SGC7901 by ursolic acid. Chin J Cancer (Chinese), 2006, 25(4): 432-437

[6] TanJ., ShenZ.X., GengW.. Ursolic acid induces apoptosis in colon cancer HT-29 cells. Chin J Oncol (Chinese), 2006, 28(2): 99-102

[7] JohnsonG.L., LapadatR.. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298(5600): 1911-1912

[8] JinY., HuJ., WangQ., et al.. Effects of oxymatrine on the apoptosis of human esophageal carcinoma Eca109 cell line and its mechanism. J Huazhong Univ Sci Technol [Med Sci], 2008, 28(3): 314-316

[9] AndresenB.T., RizzoM.A., ShomeK., et al.. The role of phosphatidic acidin the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett, 2002, 531(1): 65-68

[10] WebbC.P., von AelstL., WiglerM.H., et al.. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci, 1998, 95(15): 8773-8778

[11] HarmandP.O., DuvalR., DelageC., et al.. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int J Cancer, 2005, 114(1): 1-11

[12] DuvalR.E., HarmandP.O., Jayat-VignolesC., et al.. Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells. Oncol Rep, 2008, 19(1): 145-149

[13] KassiE., SourlingasT.G., SpiliotakiM., et al.. Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest, 2009, 27(7): 723-733

[14] TangC., LuY.H., XieJ.H., et al.. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anticancer Drugs, 2009, 20(4): 249-258

[15] MengY.Q., LiuD., CaiL.L., et al.. The synthesis of ursolic acid derivatives with cytotoxic activity and the investigation of their preliminary mechanism of action. Bioorg Med Chem, 2009, 17(2): 848-854

[16] HuangH.C., HuangC.Y., Lin-ShiauS.Y., et al.. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog, 2009, 48(6): 517-531

[17] LuS., ZhangB., WangZ.. Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis. J Huazhong Univ Sci Technol [Med Sci], 2005, 25(1): 78-81

[18] LuX., YiJ.. SUMO-1 enhancing the p53-induced HepG2 cell apoptosis. J Huazhong Univ Sci Technol [Med Sci], 2005, 25(3): 289-291

[19] IdogawaM., SasakiY., SuzukiH., et al.. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Clin Cancer Res, 2009, 15(11): 3725-3732

[20] GrinkevichV.V., NikulenkovF., ShiY., et al.. Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis. Cancer Cell, 2009, 15(5): 441-453

[21] KeppO., TesniereA., ZitvogelL., et al.. The immunogenicity of tumor cell death. Curr Opin Oncol, 2009, 21(1): 71-76

[22] WangJ., XiaoB., ZhengJ., et al.. The effect of targeted magnetic nanopaticles on hepatoma and the expression of bcl-2/bax protein. J Huazhong Univ Sci Technolog [Med Sci], 2008, 28(4): 443-446

[23] Heath-EngelH.M., ChangN.C., ShoreG.C.. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene, 2008, 27(50): 6419-6433

[24] YipK.W., ReedJ.C.. Bcl-2 family proteins and cancer. Oncogene, 2008, 27(50): 6398-6406